Matches in Wikidata for { <http://www.wikidata.org/entity/Q90933501> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q90933501 description "article scientifique publié en 2019" @default.
- Q90933501 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q90933501 description "scientific article published on 08 January 2019" @default.
- Q90933501 description "wetenschappelijk artikel" @default.
- Q90933501 description "наукова стаття, опублікована 8 січня 2019" @default.
- Q90933501 name "Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study" @default.
- Q90933501 name "Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study" @default.
- Q90933501 type Item @default.
- Q90933501 label "Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study" @default.
- Q90933501 label "Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study" @default.
- Q90933501 prefLabel "Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study" @default.
- Q90933501 prefLabel "Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study" @default.
- Q90933501 P1433 Q90933501-CC1C25F6-AA12-40E6-80F1-265FC095C302 @default.
- Q90933501 P1476 Q90933501-3DC5C39A-EF93-465A-9BC2-1282C1C04061 @default.
- Q90933501 P2093 Q90933501-047358B9-D6FB-4047-BF9D-31BB5CF65E86 @default.
- Q90933501 P2093 Q90933501-84A47CE4-75EF-4B25-8FF8-65B11E145083 @default.
- Q90933501 P2093 Q90933501-A1C25A3C-520A-4F34-8DE1-4211AEDF7F5B @default.
- Q90933501 P304 Q90933501-E6CC88BD-9F1A-4544-AFEC-F415E87D3CCD @default.
- Q90933501 P31 Q90933501-B57BA9A4-4400-49CC-B23B-F87E69331D1F @default.
- Q90933501 P356 Q90933501-87F9884E-ADB0-456F-8AAC-7681B8B547CE @default.
- Q90933501 P433 Q90933501-8BF6C7B5-1EAA-4757-8A2C-FC131EFED591 @default.
- Q90933501 P478 Q90933501-A8C533BB-FBFE-42CA-AB93-1E2C74599A60 @default.
- Q90933501 P50 Q90933501-18BAA342-F776-4242-BD1F-99B9F4735B7F @default.
- Q90933501 P50 Q90933501-2A12F3C1-3477-4700-A9A7-15C5683DC1D5 @default.
- Q90933501 P50 Q90933501-DCCFD56A-CC07-45F4-9C93-4A1C06BC482F @default.
- Q90933501 P577 Q90933501-CD850B99-0236-4DAF-BB2D-B31EFC611CEE @default.
- Q90933501 P698 Q90933501-D48F9992-4851-417C-B94F-31F08F4398C7 @default.
- Q90933501 P356 JOIM.12867 @default.
- Q90933501 P698 30618189 @default.
- Q90933501 P1433 Q6295387 @default.
- Q90933501 P1476 "Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study" @default.
- Q90933501 P2093 "Eva Rye Rasmussen" @default.
- Q90933501 P2093 "Jesper Hallas" @default.
- Q90933501 P2093 "Preben Homøe" @default.
- Q90933501 P304 "553-561" @default.
- Q90933501 P31 Q13442814 @default.
- Q90933501 P356 "10.1111/JOIM.12867" @default.
- Q90933501 P433 "5" @default.
- Q90933501 P478 "285" @default.
- Q90933501 P50 Q41547095 @default.
- Q90933501 P50 Q41670672 @default.
- Q90933501 P50 Q47545834 @default.
- Q90933501 P577 "2019-01-08T00:00:00Z" @default.
- Q90933501 P698 "30618189" @default.